Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Structure of the blood-brain barrier
-
1. The blood-brain barrier in Alzheimer’s disease
- Dr. Anika Hartz
-
2. Tanycytes allow a tight BBB in the median eminence
- Prof. Esteban Rodriguez
- Dr. Juan Luis Blazquez
- Dr. Montserrat Guerra
- Nutrient transport
-
3. Blood-brain barrier ion transport
- Prof. Martha O'Donnell
- Peptides and proteins
-
4. Ingestive peptides
- Prof. William Banks
-
5. Blood-brain barrier in health and disease
- Prof. Thomas Davis
- Overcoming the blood-brain barrier obstacle
-
6. Expression vs. function of ABC transporters at the blood-brain barrier
- Prof. Jean-Michel Scherrmann
-
7. The blood-brain barrier and CNS drug development
- Dr. Danica Stanimirovic
- Diseases involving the blood-brain barrier
-
9. Inflammation and immune cell entry to the central nervous system
- Prof. Serge Rivest
-
11. Ischemic blood-brain barrier and Alzheimer's amyloid plaques development
- Prof. Ryszard Pluta
- Latest Developments in the Field
-
12. MRI approaches for neurovascular imaging
- Dr. Rick Dijkhuizen
-
13. Brain-gut interactions in obesity 1
- Prof. Weihong Pan
-
14. Brain-gut interactions in obesity 2
- Prof. Weihong Pan
- Archived Lectures *These may not cover the latest advances in the field
-
15. Neurotrophins and the BBB
- Prof. Weihong Pan
-
16. Vasoactive peptides and the blood-brain barrier
- Prof. Maria Deli
- Prof. Bela Kis
-
17. In vivo systems
- Prof. Quentin Smith
-
18. CNS-drug design
- Prof. Quentin Smith
-
20. Stroke and the BBB
- Prof. Marilyn Cipolla
-
21. Barrier mechanisms in the developing brain: mechanisms and misunderstandings
- Prof. Norman Saunders
-
22. Barrier mechanisms in the developing brain: protection or vulnerability?
- Prof. Norman Saunders
-
23. In vitro models of the blood-brain barrier
- Prof. Pierre-Olivier Couraud
-
24. Glucose transport across the blood-brain barrier
- Prof. Luc Leybaert
-
25. The blood-brain barrier and brain tumors
- Dr. Olaf van Tellingen
-
26. Cellular composition of the blood-brain barrier
- Prof. N. Joan Abbott
-
27. Features of mammalian CNS barrier systems
- Prof. Conrad Johanson
Printable Handouts
Navigable Slide Index
- Introduction
- Vasoactive peptides
- Specific characteristics of the BBB
- Angiotensins
- Effects of angiotensin II
- Angiotensins and the BBB
- Effects of other angiotensins
- Angiotensinogen-deficient mice
- BBB and renin-angiotensin system
- Bradykinin
- Effects of bradykinin
- B2 agonist transiently opens the BBB
- Calcitonin peptide superfamily
- Heterodimeric receptors for CGRP and AM
- Adrenomedullin
- Primary cultures of the BBB cells
- Adrenomedullin production
- BBB model based on cell culture
- Astrocytes induce AM secretion from CEC
- AM concentration in the cerebral circulation
- AM acts mostly in autocrine or paracrine manner
- AM increases intracellular cAMP level in CEC
- AM increases TEER in brain endothelial cells
- Effect of chronic AM treatment on TEER
- Effects of AM on cerebral endothelial permeability
- AM activates P-glycoprotein efflux pump in CEC
- AM protects against oxidative damage in CEC
- Summary: AM and the BBB
- AM and the BBB model
- AM regulates endothelial permeability
- Calcitonin-gene related peptide
- CGRP overexpression in brain
- CGRP and the BBB
- Endothelins family
- The effects of endothelins
- Endothelins and the BBB
- Endothelins and BBB efflux pumps
- Natriuretic peptides (NPs)
- The effects of natriuretic peptides
- Natriuretic peptides and the BBB
- Pituitary adenylate cyclase activating peptide
- Effects of PACAP
- PACAP increases tightness of the barrier in CEC
- Substance P
- Effects of substance P
- Substance P and the BBB
- Urotensin
- Vasopressin
- Effects of vasopressin
- AVP stimulates the BBB Na-K-Cl cotransport
- Summary
- Acknowledgements
Topics Covered
- Blood-brain-barrier (BBB) functions, permeability pathways and transporters modulated by vasoactive peptides
- The BBB as a source and target of vasocative peptides
- Angiotensins
- Bradykinin
- Adrenomedullin
- Calcitonin-gene related peptide
- Endothelins
- Natriuretic peptides
- Pituitary adenylate cyclase activating peptide
- Substance P
- Urotensin
- Vasopressin
- Potential use of vasocative peptides as modulators of BBB functions
Talk Citation
Deli, M. and Kis, B. (2008, March 1). Vasoactive peptides and the blood-brain barrier [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/NXAG7944.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Maria Deli has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Prof. Bela Kis has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.